NCT03884530View on ClinicalTrials.gov

Ticagrelol Versus Aspirin in Ischemic Stroke

PHASE3CompletedINTERVENTIONAL
Enrollment

169

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2020

Conditions
Acute StrokeIschemic Stroke
Interventions
DRUG

Ticagrelor (Brilique) 90

Drug name Brilique 90 ml Drug form tablet

DRUG

Aspirin 75mg

Drug name Aspirin 75 ml Drug form tablet

Trial Locations (1)

33511

Neuropsychiatry department Kafrelsheikh university hospital, Kafr ash Shaykh

All Listed Sponsors
collaborator

Ain Shams University

OTHER

lead

Kafrelsheikh University

OTHER

NCT03884530 - Ticagrelol Versus Aspirin in Ischemic Stroke | Biotech Hunter | Biotech Hunter